We found that mutations predicted to disrupt the interaction between the NT “belt” and the CT region of VPS35L, including W6D, S829E, and the cancer-derived mutation G902E, abolished the binding to VPS29 without affecting VPS26C binding (Fig. 3G). Here, VPS35L is linked to cancer.